CU6 clarity pharmaceuticals ltd

Ann: SECuRE trial update, page-16

  1. 25,241 Posts.
    lightbulb Created with Sketch. 1587
    " I'll have to go back through the numbers but that seemed very low, cohort 2 all 3 were greater than 50%, cohort 3 i think all responded, where were all the no responses?"

    So as best I can work out, 5 no responders in cohort 1 at the lowest dose and 2 no responders in cohort 3? Anyone else come up with anything different?

    Cohort 3 - "Nevertheless, two-thirds (67%) of participants in this cohort so far have shown reductions in PSA greater than 35%,"

    I always had cohort 3 as 3 patients in my mind for some reason but it's 6 so it would appear that 4 had 35% or greater reductions but 2 didn't respond

    Deduction comes from all cohort 2 and 4 patients having a response, only 1 patient in cohort 1 was reported as responding(the other 5 weren't mentioned) and then the above 2/3rds of 6 from cohort 3 as responders

    Feel free to correct me
    Last edited by Hingdog: 05/03/25
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$2.39
Change
0.300(14.4%)
Mkt cap ! $768.3M
Open High Low Value Volume
$2.09 $2.40 $2.07 $8.519M 3.760M

Buyers (Bids)

No. Vol. Price($)
1 5000 $2.38
 

Sellers (Offers)

Price($) Vol. No.
$2.39 4380 2
View Market Depth
Last trade - 16.21pm 26/06/2025 (20 minute delay) ?
CU6 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.